{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:19:18Z","timestamp":1794694758582,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81773913"],"award-info":[{"award-number":["No. 81773913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81303232"],"award-info":[{"award-number":["No. 81303232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor microenvironment plays vital roles in metastasis. Modulating the tumor microenvironment via multiple pathways could efficiently prevent or inhibit lung metastasis. Silibinin and cryptotanshinone are natural plant products that demonstrate anti-metastasis effects and modulate the tumor microenvironment via different pathways. However, they have poor aqueous solubility, membrane permeability, and oral bioavailability. Oral drug administration may help improve the quality of life and compliance of patients with breast cancer, primarily under long-term and\/or follow-up therapy. Herein, we developed poly-N-(2-hydroxypropyl) methacrylamide (pHPMA)-coated wheat germ agglutinin-modified lipid-polymer hybrid nanoparticles, co-loaded with silibinin and cryptotanshinone (S\/C-pW-LPNs). We assessed their oral bioavailability, and evaluated their anti-metastasis efficacy in a 4T1 breast cancer tumor-bearing nude mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>An in vitro mucus diffusion study revealed that pHPMA enhanced W-LPN mucus penetration. After oral administration, pHPMA enhanced nanoparticle distribution in rat jejunum and substantially augmented oral bioavailability. S\/C-W-LPNs markedly increased 4T1 cell toxicity and inhibited cell invasion and migration. Compared to LPNs loaded with either silibinin or cryptotanshinone alone, S\/C-pW-LPNs dramatically slowed tumor progression in 4T1 tumor-bearing nude mice. S\/C-pW-LPNs presented with the most robust anti-metastasis activity on smooth lung surfaces and mitigated lung metastasis foci. They also downregulated tumor microenvironment biomarkers such as CD31, TGF-\u03b21, and MMP-9 that promote metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Silibinin- and cryptotanshinone-co-loaded pW-LPNs efficiently penetrate intestinal barriers, thereby enhancing the oral bioavailability of the drug loads. These nanoparticles exhibit favorable anti-metastasis effects in breast cancer-bearing nude mice. Hence, S\/C-pW-LPNs are promising oral drug nanocarriers that inhibit breast cancer lung metastasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-020-00638-x","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T09:02:44Z","timestamp":1590829364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis"],"prefix":"10.1186","volume":"18","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangpei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-2941","authenticated-orcid":false,"given":"Nianping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"key":"638_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16:201\u201318.","journal-title":"Nat Rev Cancer"},{"key":"638_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massagu\u00e9","year":"2016","unstructured":"Massagu\u00e9 J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306.","journal-title":"Nature"},{"key":"638_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jjco\/hyn133","volume":"39","author":"D Gao","year":"2009","unstructured":"Gao D, Du J, Cong L, Liu Q. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I\u2013III of operable patients. Jpn J Clin Oncol. 2009;39:97\u2013104.","journal-title":"Jpn J Clin Oncol"},{"key":"638_CR4","doi-asserted-by":"publisher","first-page":"119769","DOI":"10.1016\/j.biomaterials.2020.119769","volume":"235","author":"H Xu","year":"2020","unstructured":"Xu H, Hu M, Liu M, An S, Guan K, Wang M, Li L, Zhang J, Li J, Huang L. Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 2020;235:119769.","journal-title":"Biomaterials"},{"key":"638_CR5","doi-asserted-by":"publisher","first-page":"152729","DOI":"10.1016\/j.prp.2019.152729","volume":"216","author":"PI Ribeiro Franco","year":"2020","unstructured":"Ribeiro Franco PI, Rodrigues AP, de Menezes LB, Pacheco Miguel M. Tumor microenvironment components: allies of cancer progression. Pathol Res Pract. 2020;216:152729.","journal-title":"Pathol Res Pract"},{"key":"638_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nantod.2018.06.008","volume":"21","author":"JJ Liu","year":"2018","unstructured":"Liu JJ, Chen Q, Feng LZ, Liu Z. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement. Nano Today. 2018;21:55\u201373.","journal-title":"Nano Today."},{"key":"638_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/15680096113139990041","volume":"13","author":"G Deep","year":"2013","unstructured":"Deep G, Agarwal R. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy. Curr Cancer Drug Targets. 2013;13:486\u201399.","journal-title":"Curr Cancer Drug Targets"},{"key":"638_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pharmthera.2016.03.001","volume":"162","author":"MK Apaya","year":"2016","unstructured":"Apaya MK, Chang MT, Shyur LF. Phytomedicine polypharmacology: cancer therapy through modulating the tumor microenvironment and oxylipin dynamics. Pharmacol Ther. 2016;162:58\u201368.","journal-title":"Pharmacol Ther"},{"key":"638_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10555-010-9237-0","volume":"29","author":"G Deep","year":"2010","unstructured":"Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev. 2010;29:447\u201363.","journal-title":"Cancer Metastasis Rev"},{"key":"638_CR10","first-page":"3767","volume":"31","author":"S Kim","year":"2011","unstructured":"Kim S, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Anticancer Res. 2011;31:3767.","journal-title":"Anticancer Res"},{"key":"638_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1940-6207.CAPR-15-0123","volume":"9","author":"M Lazzeroni","year":"2016","unstructured":"Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Puccio A, Mora S, Caldarella P, Pagani G, Pruneri G, Riva A, Petrangolini G, Morazzoni P, DeCensi A, Bonanni B. A Presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancer. Cancer Prev Res. 2016;9:89\u201395.","journal-title":"Cancer Prev Res."},{"key":"638_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fphar.2019.00715","volume":"10","author":"L Avila-Carrasco","year":"2019","unstructured":"Avila-Carrasco L, Majano P, S\u00e1nchez-Tom\u00e9ro JA, Selgas R, L\u00f3pez-Cabrera M, Aguilera A, Gonz\u00e1lez Mateo G. Natural plant compounds as modulators of epithelial-to-mesenchymal transition. Front Pharmacol. 2019;10:715.","journal-title":"Front Pharmacol."},{"key":"638_CR13","doi-asserted-by":"publisher","first-page":"22232","DOI":"10.1039\/C5RA22523J","volume":"27","author":"XM Liu","year":"2016","unstructured":"Liu XM, Pan LL, Liang JL, Li JH, Wu SH. Cryptotanshinone inhibits proliferation and induces apoptosis via mitochondria-derived reactive oxygen species involving FOXO1 in estrogen receptor-negative breast cancer Bcap37 cells. RSC Adv. 2016;27:22232\u201343.","journal-title":"RSC Adv."},{"key":"638_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4161\/15384047.2014.962960","volume":"16","author":"S Li","year":"2015","unstructured":"Li S, Wang H, Hong L, Liu W, Huang F, Wang J, Wang P, Zhang X, Zhou J. Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling. Cancer Biol Ther. 2015;16:176\u201384.","journal-title":"Cancer Biol Ther"},{"key":"638_CR15","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.7314\/APJCP.2014.15.6.2439","volume":"15","author":"J Zhou","year":"2014","unstructured":"Zhou J, Xu XZ, Hu YR, Hu AR, Zhu CL, Gao GS. Cryptotanshinone induces inhibition of breast tumor growth by cytotoxic CD4\u2009+\u2009T cells through the JAK2\/STAT4\/perforin pathway. Asian Pac J Cancer Prev. 2014;15:2439\u201345.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"638_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10495-011-0680-3","volume":"17","author":"IJ Park","year":"2012","unstructured":"Park IJ, Kim MJ, Park OJ, Choe W, Kang I, Kim SS, Ha J. Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells. Apoptosis. 2012;17(3):248\u201357.","journal-title":"Apoptosis"},{"issue":"1","key":"638_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2013.04.020","volume":"170","author":"K Thanki","year":"2013","unstructured":"Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013;170(1):15\u201340.","journal-title":"J Control Release"},{"issue":"6","key":"638_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.addr.2012.11.005","volume":"65","author":"L Mei","year":"2013","unstructured":"Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, Feng SS. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65(6):880\u201390.","journal-title":"Adv Drug Deliv Rev"},{"key":"638_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2013.12.030","volume":"176","author":"C Luo","year":"2014","unstructured":"Luo C, Sun J, Du YQ, He ZG. Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy. J Control Release. 2014;176:94\u2013103.","journal-title":"J Control Release"},{"key":"638_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2016.07.008","volume":"237","author":"JJ Qin","year":"2016","unstructured":"Qin JJ, Wang W, Sarkar S, Zhang R. Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis. J Control Release. 2016;237:101\u201314.","journal-title":"J Control Release"},{"key":"638_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jconrel.2015.01.015","volume":"205","author":"HQ Cao","year":"2015","unstructured":"Cao HQ, Zhang ZW, Zhao S, He XY, Yu HJ, Yin Q, Zhang ZP, Gu WW, Chen LL, Li YP. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression. J Control Release. 2015;205:162\u201371.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"638_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2011.01.060","volume":"408","author":"S D\u00fcnnhaupt","year":"2011","unstructured":"D\u00fcnnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop-Schn\u00fcrch A. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Int J Pharm. 2011;408(1\u20132):191\u20139.","journal-title":"Int J Pharm"},{"issue":"7","key":"638_CR23","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.nano.2017.05.003","volume":"13","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liu JG, Liang J, Zhang MY, Li Z, Wang Z, Dang BL, Feng NP. Mucosal transfer of wheat germ agglutinin modified lipid\u2013polymer hybrid nanoparticles for oral delivery of oridonin. Nanomedicine. 2017;13(7):2219\u201329.","journal-title":"Nanomedicine."},{"key":"638_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","volume":"222","author":"M Liu","year":"2016","unstructured":"Liu M, Zhang J, Zhu X, Shan W, Li L, Zhong JJ, Zhang ZR, Huang Y. Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery. J Control Release. 2016;222:67\u201377.","journal-title":"J Control Release"},{"key":"638_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2015.10.003","volume":"240","author":"JY Yang","year":"2016","unstructured":"Yang JY, Jindrich K. Design of smart HPMA copolymer-based nanomedicines. J Control Release. 2016;240:9\u201323.","journal-title":"J Control Release"},{"key":"638_CR26","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.nano.2019.102075","volume":"21","author":"Y Liu","year":"2019","unstructured":"Liu Y, Jiang ZF, Hou XF, Xie XX, Shi JP, Shen JY, He YZ, Wang Z, Feng NP. Functional lipid polymeric nanoparticles for oral drug delivery: rapid mucus penetration and improved cell entry and cellular transport. Nanomedicine. 2019;21:102075.","journal-title":"Nanomedicine."},{"key":"638_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","volume":"8","author":"LF Kou","year":"2013","unstructured":"Kou LF, Sun J, Zhai YL, He ZG. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8:1\u201310.","journal-title":"Asian J Pharm Sci"},{"issue":"2\u20133","key":"638_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cocis.2005.11.001","volume":"11","author":"R Bansil","year":"2006","unstructured":"Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci. 2006;11(2\u20133):164\u201370.","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"14","key":"638_CR29","doi-asserted-by":"publisher","first-page":"11443","DOI":"10.1021\/acsami.7b19153","volume":"10","author":"D Yang","year":"2018","unstructured":"Yang D, Liu DC, Qin MM, Chen BL, Song SY, Dai WB, Zhang H, Wang XQ, Wang YG, He B, Tang X, Zhang Q. Intestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering nanoclustering and strengthening the retrograde pathway. ACS Appl Mater Interfaces. 2018;10(14):11443\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"42","key":"638_CR30","doi-asserted-by":"publisher","first-page":"36125","DOI":"10.1039\/C6RA04023C","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zhao YQ, Liu JG, Zhang MY, Yu ML, Feng NP. Wheat germ agglutinin modification of lipid-polymer hybrid nanoparticles: enhanced cellular uptake and bioadhesion. RSC Adv. 2016;6(42):36125\u201335.","journal-title":"RSC Adv."},{"issue":"2","key":"638_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.abb.2004.03.020","volume":"426","author":"HA Lucero","year":"2004","unstructured":"Lucero HA, Robbins PW. Lipid rafts-protein association and the regulation of protein activity. Arch Biochem Biophys. 2004;426(2):208\u201324.","journal-title":"Arch Biochem Biophys"},{"key":"638_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neures.2017.11.002","volume":"128","author":"Y Ito","year":"2018","unstructured":"Ito Y, Honda A, Igarashi M. Glycoprotein M6a as a signaling transducer in neuronal lipid rafts. Neurosci Res. 2018;128:19\u201324.","journal-title":"Neurosci Res"},{"key":"638_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","volume":"144","author":"S Patel","year":"2019","unstructured":"Patel S, Kim J, Herrera M, Mukherjee A, Kabanov AV, Sahay G. Brief update on endocytosis of nanomedicines. Adv Drug Deliv Rev. 2019;144:90\u2013111.","journal-title":"Adv Drug Deliv Rev"},{"key":"638_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.phymed.2018.07.001","volume":"55","author":"B Salehi","year":"2019","unstructured":"Salehi B, Varoni EM, Sharifi-Rad M, Rajabi S, Zucca P, Iriti M, Sharifi-Rad J. Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis. Phytomedicine. 2019;55:125\u201336.","journal-title":"Phytomedicine"},{"issue":"5","key":"638_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1080\/10408398.2018.1551778","volume":"60","author":"HF Gu","year":"2020","unstructured":"Gu HF, Mao XY, Du M. Prevention of breast cancer by dietary polyphenols-role of cancer stem cells. Crit Rev Food Sci Nutr. 2020;60(5):810\u201325.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"638_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10020-018-0032-7","volume":"24","author":"D Avtanski","year":"2018","unstructured":"Avtanski D, Poretsky L. Phyto-polyphenols as potential inhibitors of breast cancer metastasis. Mol Med. 2018;24:29.","journal-title":"Mol Med"},{"key":"638_CR37","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3892\/or.2017.5588","volume":"37","author":"HJ Byun","year":"2017","unstructured":"Byun HJ, Darvin P, Kang DY, Sp N, Joung YH, Park JH, Kim SJ, Yang YM. Silibinin downregulates MMP2 expression via Jak2\/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells. Oncol Rep. 2017;37:3270\u20138.","journal-title":"Oncol Rep"},{"key":"638_CR38","first-page":"299","volume":"16","author":"N Mahmoodi","year":"2014","unstructured":"Mahmoodi N, Motamed N, Paylakhi SH. The comparison of the effects of silybin and silybin-phosphatidylcholine on viability and ESR expression in human breast cancer T47D cell line. Cell J. 2014;16:299\u2013308.","journal-title":"Cell J."},{"key":"638_CR39","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3892\/mmr.2014.2093","volume":"9","author":"L Chen","year":"2014","unstructured":"Chen L, Wang HJ, Xie W, Yao Y, Zhang YS, Wang H. Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo. Mol Med Rep. 2014;9:2447\u201352.","journal-title":"Mol Med Rep."},{"key":"638_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2013.06.053","volume":"454","author":"P Xu","year":"2013","unstructured":"Xu P, Yin Q, Shen J, Chen L, Yu H, Zhang Z, Li Y. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. Int J Pharm. 2013;454:21\u201330.","journal-title":"Int J Pharm"},{"key":"638_CR41","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/aps.2017.74","volume":"38","author":"XY Dong","year":"2017","unstructured":"Dong XY, Lang TQ, Yin Q, Zhang PC, Li YP. Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer. Acta Pharmacol Sin. 2017;38:1655\u201362.","journal-title":"Acta Pharmacol Sin"},{"key":"638_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/aps.2016.20","volume":"37","author":"HP Sun","year":"2016","unstructured":"Sun HP, Su JH, Meng QS, Yin Q, Zhang ZW, Yu HJ, Zhang PC, Wang SL, Li YP. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro. Acta Pharmacol Sin. 2016;37:941\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"638_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini H, Obradovi\u0107 MMS, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, Nanduri LK, Werno C, Ehrl C, Maneck M, Patwary N, Haunschild G, Gu\u017evi\u0107 M, Reimelt C, Grauvogl M, Eichner N, Weber F, Hartkopf AD, Taran FA, Brucker SY, Fehm T, Rack B, Buchholz S, Spang R, Meister G, Aguirre-Ghiso JA, Klein CA. Early dissemination seeds metastasis in breast cancer. Nature. 2016;540:552\u20138.","journal-title":"Nature"},{"key":"638_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14737159.2018.1439382","volume":"18","author":"S Mittal","year":"2018","unstructured":"Mittal S, Brown NJ, Holen I. The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn. 2018;18:227\u201343.","journal-title":"Expert Rev Mol Diagn."},{"key":"638_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/bcr2912","volume":"13","author":"AE Place","year":"2011","unstructured":"Place AE, Jin Huh S, Polyak K. The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res. 2011;13:227.","journal-title":"Breast Cancer Res"},{"key":"638_CR46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2407-12-192","volume":"12","author":"X Wu","year":"2012","unstructured":"Wu X, Zhang Y, Pei Z, Chen S, Yang X, Chen Y, Lin D, Ma RZ. Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2. BMC Cancer. 2012;12:192.","journal-title":"BMC Cancer."},{"key":"638_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12282-011-0321-2","volume":"19","author":"T Imamura","year":"2012","unstructured":"Imamura T, Hikita A, Inoue Y. The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis. Breast Cancer. 2012;19:118\u201324.","journal-title":"Breast Cancer."},{"key":"638_CR48","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/onc.2010.563","volume":"30","author":"X Wang","year":"2011","unstructured":"Wang X, Lu H, Urvalek AM, Li T, Yu L, Lamar J, DiPersio CM, Feustel PJ, Zhao J. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene. 2011;30:1901\u201311.","journal-title":"Oncogene"},{"key":"638_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tips.2019.04.005","volume":"40","author":"X Zhuang","year":"2019","unstructured":"Zhuang X, Zhang H, Hu G. Cancer and microenvironment plasticity: double-edged swords in metastasis. Trends Pharmacol Sci. 2019;40:419\u201329.","journal-title":"Trends Pharmacol Sci"},{"key":"638_CR50","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","volume":"9","author":"W Shan","year":"2015","unstructured":"Shan W, Zhu X, Liu M, Li L, Zhong J, Sun W, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano. 2015;9:2345\u201356.","journal-title":"ACS Nano"},{"key":"638_CR51","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/mp500475y","volume":"12","author":"JB Zhang","year":"2015","unstructured":"Zhang JB, Lv Y, Wang B, Zhao S, Tan MQ, Lv GJ, Ma XJ. Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions. Mol Pharm. 2015;12:695\u2013705.","journal-title":"Mol Pharm"},{"key":"638_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2017.11.034","volume":"536","author":"T Yin","year":"2018","unstructured":"Yin T, Zhang Y, Liu Y, Chen Q, Fu Y, Liang J, Zhou J, Tang X, Liu J, Huo M. The efficiency and mechanism of N-octyl-O, N-carboxymethyl chitosan-based micelles to enhance the oral absorption of silybin. Int J Pharm. 2018;536:231\u201340.","journal-title":"Int J Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-020-00638-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T23:08:37Z","timestamp":1622329717000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-020-00638-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1186\/s12951-020-00638-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal studies were approved by the animal ethics committee of the Institutional Animal Care and Use Committee, Shanghai University of TCM.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}